Research Coordinating Committee (RCC)
The Research Coordinating Committee (RCC) is responsible for the scientific strategy of the DZHK. It develops ideas, addresses strategy-relevant issues and prepares all matters for the General Assembly. The RCC meets monthly and comprises the Board of Directors, the partner site speakers, representatives from each partner institution and a representative of the Young-DZHK. Several permanent guests represent important DZHK-activities such as the Clinical Research Platform.
Translational Research Group (TRG)
To get translation projects off the ground within the context of the DZHK research strategy, the DZHK has established a Translational Research Group (TRG) in which external researchers are also represented. The TRG provides guidance and support for translational research projects in the initial phase. Its tasks also include aspects of commercialisation, the assessment of translational research proposals and the preparation of decisions in the DZHK bodies. Along with this, the TRG combines and expands the knowledge base for the development of new therapeutic principles within the DZHK.
Members of the TRG (alphabetical):
- Bechem, Martin
- Daemen, Mat | Amsterdam (Spokesperson)
- Ehmke, Heimo | Hamburg/Kiel/Lübeck (Spokesperson)
- Krappa, Ralf | Hamburg/Kiel/Lübeck
- Landmesser, Ulf | Berlin
- Lehnart, Stephan E. Göttingen.
- Most, Patrick | Heidelberg/Mannheim
- Ulm, Kurt | Munich
- Ungerer, Martin | Munich
Clinical Study Group (CSG)
The Clinical Study Group CSG consists of DZHK external and internal members. It advises the board and the RCC (in delegation for the General Assembly) on the selection and controlling of the sponsored #clinical trials.
Members of the CSG:
- Harry Crijns, Maastricht (Spokesperson)
- Stefan Anker, Berlin (Spokesperson)
- Stefan Blankenberg, Hamburg/Kiel/Lübeck (Deputy Spokesperson)
- Martin Borggrefe, Heidelberg/Mannheim
- John Cleland, London
- Tim Friede, Göttingen
- Eva Herrmann, Rhine-Main
- Jeanette Schulz-Menger, Berlin
- Thomas Voit, London
- Karl Wegscheider, Hamburg/Kiel/Lübeck
- Wolfram Zimmermann, Göttingen
- Frank Edelmann, Berlin
- Dana Stahl, Greifswald
Working Group Clinical Research (WGCR)
The Working Group Clinical Research (WGCR) facilitates the exchange between principal investigators of DZHK studies, cooperation partners of the Clinical Research Platform and study centres (Clinical Staff) in order to promote patient enrolment in DZHK studies, to ensure quality standards or to optimize clinical research workflows. The WGCR is thus a working committee and decision-making body for the DZHK rules and regulations in the clinical field.
Use & Access Committee
Considering the high scientific value of the #DZHK resources and the high requirements regarding patient rights, applications for data and biomaterials of the DZHK collection wil be evaluated with regard to their scientific objective and benefit. The independent Use and Access Committee (U&AC) takes over these tasks according to transparent criteria according to the #DZHK Use and Access Policy. Representatives of each DZHK partner site, biobank, ethics and statistics experts, as well as external consultants have been appointed to the committee.
Young DZHK Postdoc Committee